10-K/A: Healthcare AI Acquisition Corp. Files Amended 10-K After Audit Error

Healthcare AI Acquisition Corp. has filed an amended annual report to correct an error related to the audit report, with no other changes to the original filing.

Summary

• Healthcare AI Acquisition Corp. filed an amendment to its annual report on Form 10-K for the fiscal year ended December 31, 2023.
• The amendment was necessary to include the correct audit report from BF Borgers CPA PC, as the original filing was inadvertently submitted with the wrong audit report.
• The company is a blank check company formed for the purpose of a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.
• As of December 31, 2023, the company had $6,539,002 available to consummate an initial business combination.
• The company has until December 14, 2024, to complete a business combination.
• The company's initial public offering (IPO) on December 14, 2021, generated gross proceeds of $215,624,010.
• Simultaneously with the IPO, the company sold 11,124,960 private placement warrants for $11,124,960.
• A total of $219,936,490 was placed in a trust account.
• On June 8, 2023, the company transferred sponsorship to Atticus Ale, LLC.
• Following the sponsor handover, 19,824,274 shares were redeemed by public shareholders for $10.54 per share, removing $208,992,255 from the trust account.
• On June 29, 2023, the company issued 5,390,599 Class A shares upon conversion of Class B shares.
• On August 11, 2023, 1,146,276 shares were further redeemed for $10.73 per share, removing $12,302,385 from the trust account.
• The company has identified a material weakness in its internal control over financial reporting.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the restatement, material weakness in internal controls, and going concern issues. While the company has funds for a business combination, the risks and uncertainties are significant.

Positives

• The company has a clear deadline for completing a business combination, which provides a timeline for investors.
• The company has a significant amount of capital available for a business combination.
• The company has taken steps to correct errors in its financial reporting.

Negatives

• The company has identified a material weakness in its internal control over financial reporting.
• The company has incurred significant costs in pursuit of its financing and acquisition plans.
• The company's ability to continue as a going concern is in doubt.

Risks

• The company may not be able to complete a business combination by December 14, 2024.
• The company may not be able to find a suitable target business.
• The company may be affected by numerous risks inherent in a target business.
• The company may need to obtain additional financing to complete a business combination.
• The company's internal control over financial reporting has a material weakness.
• The company may be deemed an investment company under the Investment Company Act of 1940.
• The company's public shareholders may not have the opportunity to vote on the proposed initial business combination.
• The company's public shareholders may be incentivized to redeem their shares.
• The company may be subject to claims from third parties, reducing the funds in the trust account.
• The company may be affected by geopolitical tensions and market volatility.

Future Outlook

The company is focused on identifying and completing a business combination by December 14, 2024, but there is no guarantee of success.

Management Comments

• Management anticipates that the cash held outside of the Trust Account as of December 31, 2023 might not be sufficient to allow the Company to operate until December 14, 2024.
• Management has determined that mandatory liquidation, and subsequent dissolution, should the Company be unable to complete a business combination, raises substantial doubt about the Companys ability to continue as a going concern for the next twelve months from the issuance of these financial statements.

Industry Context

This announcement is typical for a special purpose acquisition company (SPAC) that is nearing its deadline to complete a business combination. The amendment highlights the challenges and risks associated with SPACs, including the need for strong internal controls and the potential for delays or errors in financial reporting.

Comparison to Industry Standards

• The company's structure and timeline are consistent with typical SPACs, which aim to complete a business combination within a set timeframe, usually 18-24 months.
• The redemption of shares by public shareholders is a common occurrence in SPACs, especially when the deadline for a business combination approaches.
• The company's identification of a material weakness in internal control is not uncommon for SPACs, which often have limited operating history and resources.
• The company's financial position, with a significant amount of cash in trust and limited operating expenses, is typical for a SPAC in its pre-combination phase.
• The company's reliance on its sponsor for working capital loans is also a common practice in the SPAC industry.
• Compared to other SPACs, the company's trust account contained $10.20 per share, which is higher than the $10.00 per share seen in some other SPACs, potentially incentivizing shareholders to redeem their shares.

Management Changes

Corporate Governance

Related Party Transactions

• The company has entered into agreements with its sponsor and related parties for loans, administrative services, and other transactions.
• The company has a promissory note with the New Sponsor and New Sponsors shareholder.
• The company has a working capital loan with the New Sponsor.
• The company had an administrative services agreement with the Former Sponsor, which was waived upon Sponsor Handover.

Stakeholder Impact

• Shareholders face the risk of losing their investment if a business combination is not completed by December 14, 2024.
• Shareholders may be required to redeem their shares if they do not approve of a proposed business combination.
• Employees of a potential target company may be affected by the terms of a business combination.
• Creditors may have claims against the trust account, potentially reducing the amount available for shareholders.
• The company's sponsor and management team have agreed to waive their redemption rights with respect to their founder shares.

Next Steps

• The company will continue to seek a suitable business combination target.
• The company will work to remediate the material weakness in its internal control over financial reporting.
• The company will need to secure additional financing if required to complete a business combination.

Key Dates

Keywords

business combination, SPAC, acquisition, merger, warrants, redemption, trust account, audit report, financial reporting, internal control